LTRN
Lantern Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LTRN fundamentals
Lantern Pharma (LTRN) released its earnings on Nov 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.39 (YoY +7.14%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.39
+7.14%
Report date
Nov 12, 2025
LTRN Earnings Call Summary for Q3,2025
- Clinical Success: LP-184 Phase Ia shows 48% clinical benefit rate; LP-300 achieves 86% response rate in never-smokers.
- AI Breakthrough: RADR modules deliver 94% BBB permeability accuracy; withZeta enables rapid rare cancer drug discovery.
- Cash Runway: $12.4M supports operations into Q3 2026; $1.6M raised via ATM in Q3.
- Strategic Growth: $7B+ addressable market for LP-184 trials; Zeta to transform rare cancer R&D with 500K+ trial insights.
EPS
Revenue
Revenue & Expenses
Key Indicators
Lantern Pharma (LTRN) key financial stats and ratios, covering profitability, financial health, and leverage.
Lantern Pharma (LTRN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lantern Pharma (LTRN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lantern Pharma (LTRN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lantern Pharma (LTRN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lantern Pharma (LTRN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Lantern Pharma’s earnings call?What is the revenue and EPS growth rate for Lantern Pharma year over year?What does Lantern Pharma do and what are its main business segments?What factors drove the changes in Lantern Pharma's revenue and profit?Did Lantern Pharma beat or miss consensus estimates last quarter?What is Lantern Pharma's gross profit margin?What is the market's earnings forecast for Lantern Pharma next quarter?What is Lantern Pharma's latest dividend and current dividend yield?
